Hemangioblastoma

Hemangioblastoma is a rare, benign tumor arising primarily within the central nervous system, especially the cerebellum, spinal cord, and brainstem.

Composed of abnormal blood vessel cells, these tumors are often slow-growing and well-circumscribed, making them amenable to surgical removal. Hemangioblastomas can appear sporadically or as part of Von Hippel-Lindau (VHL) disease, a genetic disorder associated with multiple tumors and cysts throughout the body. Patients may present with headaches, dizziness, difficulty with coordination, or neurological deficits depending on tumor location and size.

Diagnostic evaluation includes MRI or CT scans, which typically reveal a highly vascular mass; angiography may further clarify vascular anatomy. The mainstay of treatment is surgical resection, which is usually curative for solitary tumors. However, recurrent or multifocal cases, especially those associated with VHL, may require repeated interventions or adjunctive therapies such as stereotactic radiosurgery. Prognosis is generally excellent for isolated cases, but regular follow-up is essential for individuals with VHL due to the higher risk of recurrence or new tumor formation. Early diagnosis and intervention are critical to minimize neurological damage and optimize long-term outcomes. Advances in imaging and microsurgical techniques continue to improve prognosis and quality of life for affected patients.